Haranaka, Miwa http://orcid.org/0000-0001-6813-3131
Baber, James http://orcid.org/0000-0001-6798-4399
Ogama, Yoichiro
Yamaji, Masako
Aizawa, Masakazu
Kogawara, Osamu
Scully, Ingrid http://orcid.org/0000-0001-8249-0397
Lagkadinou, Eleni
Türeci, Ӧzlem http://orcid.org/0000-0002-0623-1497
Şahin, Uğur http://orcid.org/0000-0003-0363-1564
Dormitzer, Philip R. http://orcid.org/0000-0003-0671-6360
Gruber, William C.
Lockhart, Stephen http://orcid.org/0000-0002-0805-2193
Funding for this research was provided by:
Pfizer (n/a)
Article History
Received: 2 August 2021
Accepted: 12 November 2021
First Online: 14 December 2021
Competing interests
: J.B., M.Y., M.A., O.K., I.S., P.D., W.G. and S.L. are employees of Pfizer Inc and may hold stock or stock options. E.L., Ӧ.T. and U.Ş. are employees of BioNTech Inc and may hold stock or stock options. M.H. and Y.O. have no competing interests.